← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 19, 2017Last known activity
Jun 15, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (5)
- NCT05766553Lead sponsorN/AJun 15, 2023
- NCT04950426Overall official - principal investigatorPhase 2Sep 9, 2021
- NCT04950426Lead sponsorPhase 2Sep 9, 2021
- NCT03277339Overall official - principal investigatorPhase 4Jan 19, 2017
- NCT03277339Lead sponsorPhase 4Jan 19, 2017
Details
- Last known activity
- Jun 15, 2023